PS www.ProStocks.com
|
|
Incorporated in 2012, Ahmedabad-based Earum Pharmaceuticals Limited is engaged in trading, marketing, distribution of pharmaceutical formulation products. The company has 125 drugs formulation products including multivitamins, gynaecology drugs, steroids, anti-biotic drugs, cerebral activator drugs, gastrointestinal drugs, etc.
The company is also involved in the trading business of active pharmaceutical ingredients (API's) including Amoxicillin Trihydrate IP, Levofloxacin Hemihydrate IP and Albendazole IP. Earum Pharmaceuticals is primarily engaged in two types of business activities; marketing of its own formulations products and trading of other brands' generic formulations. Currently, it has around 24 products which are manufactured by 3rd parties and marketed by the company under its brand name.
It has a warehouse at Ahmedabad, Gujarat equipped with all amenities to process business operations smoothly. The company has a domestic and international presence across South East Asia, Latin America and Africa.
Future goals of Earum Pharmaceuticals Ltd are:
1. Make global presence more prominent
2. Enhance customer satisfaction by improving market skills
3. Deal in quality standard products
The competitive strengths of the company are:
1. Wide product range
2. The experienced promoter of 11+ years experience
3. Quality assurance
| IPO Date | Jun 21, 2019 to Jun 26, 2019 |
| Listing Date | Jul 4, 2019 |
| Face Value | ₹10 per share |
| Price | ₹36 per share |
| Lot Size | 3000 Shares |
| Total Issue Size | 1,848,000 shares (aggregating up to ₹6.65 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Other Shares Offered | 876,000 (50.00%) |
| Retail Shares Offered | 876,000 (50.00%) |
| Market Maker portion | 96,000 shares |
| Total Shares Offered | 1,752,000 |
Earum IPO opens on Jun 21, 2019, and closes on Jun 26, 2019.
| Event | Tentative Date |
|---|---|
| Opening Date | Jun 21, 2019 |
| Closing Date | Jun 26, 2019 |
| Basis of Allotment | Jul 1, 2019 |
| Initiation of Refunds | Jul 2, 2019 |
| Credit of Shares to Demat | Jul 3, 2019 |
| Listing Date | Jul 4, 2019 |
| UPI Mandate Confirmation Cut-Off Time | 5.00 PM on the issue closing day |
The Earum IPO lot size is 3000 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 3000 | ₹108,000 |
| Retail (Max) | 1 | 3000 | ₹108,000 |
| Lot Size Calculator | |||
Mr. Bhumishth Narendrabhai Patel and Mrs. Payal Bhumishth Patel are the promoters of the company.
| Pre Issue Share Holding | 100% |
| Post Issue Share Holding | 70.04% |
The Earum IPO is subscribed 1.60 times on Jun 26, 2019 6:50:02 PM. The public issue subscribed 1.48 times in the retail category, times in the QIB category, and 1.72 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| Other | 1.72 |
| Retail | 1.48 |
| Total | 1.60 |
| Particulars | For the year/period ended (in Rs. Lakhs) | ||||
|---|---|---|---|---|---|
| 31-Dec-18 | 31-Mar-18 | 31-Dec-17 | 31-Mar-16 | ||
| Total Assets | 2,741.00 | 2,052.88 | 1,108.45 | 878.71 | |
| Total Revenue | 3,449.85 | 3,543.67 | 2,333.95 | 1,856.66 | |
| Profit After Tax | 86.51 | 85.65 | 15.98 | 9.76 | |
[Dilip Davda]
EPL does not own manufacturing unit and is engaged in trading activities only. The issue is fully priced. Third-party contract business raises concern. Currently, the pharma sector is not fancied by investors. Merchant Banker has average track records. Considering all these, investors may skip this issue.
The company intends to utilize the proceeds of the Issue to meet the following objects:-
1. To meet Working Capital requirements
2. General Corporate Purpose
3. To meet issue expenses
| Listing Date | Jul 4, 2019 |
| BSE Script Code | 542724 |
| NSE Symbol | |
| ISIN | INE060601015 |
| Final Issue Price | ₹36 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| BSE SME |
|---|
| ₹36.00 |
| ₹36.00 |
| ₹36.00 |
| ₹36.15 |
| ₹36.05 |
Earum Pharmaceuticals Limited
G1, Ground Floor, V R Complex,
Near Sanathal Cross Road, SP Ring Road,
Sanathal, Ahmedabad, Gujarat-382210,
Phone: +91-79-48402525
Email: cs@earumpharma.com
Website: http://www.earumpharma.com/
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://www.bigshareonline.com/
Are you an SME company looking for an IPO to raise funds and get listed in the stock market? We can help. Contact us today... SME IPO Enquiry Form
Earum IPO is a SME IPO of 1,848,000 equity shares of the face value of ₹10 aggregating up to ₹6.65 Crores. The issue is priced at ₹36 per share. The minimum order quantity is 3000 Shares.
The IPO opens on Jun 21, 2019, and closes on Jun 26, 2019.
Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
The Earum IPO opens on Jun 21, 2019 and closes on Jun 26, 2019.
Earum IPO lot size is 3000 Shares and the minimum order quantity is .
You can apply in Earum IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Earum IPO will be done on Jul 1, 2019, and the allotted shares will be credited to your demat account by Jul 3, 2019. Check the Earum IPO allotment status.
Useful Articles
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|
|
RHP
IPO Guru (1600+ Posts, 900+ Likes)
